Andhra Cements Limited Overview
Andhra Cements Limited is one of India's oldest cement makers, incorporated in 1936. Today it is a single-segment regional cement producer with one operating integrated plant at Dachepalli in Andhra Pradesh's Palnadu district. After a decade of losses under successive promoters, including the Jaypee Group from 2012, it shut down in February 2020. It was then taken through insolvency under the Insolvency and Bankruptcy Code. Sagar Cements Limited acquired it through an NCLT-approved resolution plan in February 2023. Since then ACL has served as Sagar's capacity-expansion vehicle in coastal and central Andhra Pradesh. It restarted grinding in April 2023, commissioned a six-stage preheater in October 2025, and raised grinding capacity from 1.82 to 3.00 MTPA in September 2026. The company remains loss-making and highly leveraged, and it depends on its parent for funding. The pending amalgamation into Sagar Cements is now the central fact of its investment case.
What the company does. ACL manufactures and sells cement and cement-related products. Its results filings state that this is a single reportable business segment under Ind AS 108 (Q1 FY2027 results, note 2). Production is concentrated at Sri Durga Cement Works. DCW is an integrated plant with captive limestone mining, clinkerisation and cement grinding. Sagar Cements' February 2023 acquisition presentation to BSE described DCW as an integrated unit with a captive limestone mine and VCW as a grinding-only unit.
Business model. ACL is a commodity manufacturer. Revenue is almost entirely product sales of cement, plus clinker sales where applicable. There is no meaningful service, subscription or licensing revenue. The cost structure is dominated by energy and logistics. In FY2026, power and fuel (INR 177.83 crore) and freight and forwarding (INR 99.29 crore) together equalled about 63% of revenue from operations of INR 442.49 crore (FY2026 audited results, NSE, 13 May 2026).
Revenue model mix.
Value-chain position. ACL sits in the upstream-to-midstream part of the building-materials value chain. It mines limestone, produces clinker, grinds cement and sells through dealers and directly to institutional buyers. Sales and marketing are integrated with the parent's network. Sagar's investor materials report Sagar-group sales by trade and non-trade channel and by state. ACL's own channel mix is not separately disclosed, but its volumes are sold within the Sagar platform.
Customer types and end-markets. As a regional cement producer, ACL serves two groups:
-
individual home builders through dealer/retail ("trade") channels; and
-
infrastructure contractors, real-estate developers and government projects ("non-trade").
Sagar management has cited Amaravati capital-region development, Telangana's housing scheme and stronger private construction as South India demand drivers. Management expects 8–10% South India demand growth in FY2027 (ICICI Securities via DSIJ, Q1 FY2027).
Company's own description. The FY2026 Annual Report (182 pages, filed with BSE) summarises the year as follows. Plant operations at Sri Durga Cement Works resumed and continued. The modernisation and expansion project to reach 3 MTPA grinding capacity progressed. Minimum Public Shareholding of 25% was achieved through a parent Offer for Sale. Revenue rose to INR 44,249 lakh, but the year still ended in a net loss of INR 6,716 lakh (summary via SustainabilityReports.com index of the FY2026 AR).
Independent characterisation. ACL is a turnaround asset inside a mid-sized group, not a standalone franchise. Its strategic value to Sagar lies in three things:
-
its limestone reserves and an integrated clinker line in the Guntur–Palnadu belt, a historic limestone cluster;
-
a brownfield expansion that is cheap per tonne compared with greenfield; and
-
accumulated tax losses that the amalgamation can use against Sagar's profits.
Its operating weaknesses are equally clear: low utilisation (about 41% in Q1 FY2027 per Sagar management), EBITDA margins in low single digits, and finance costs that exceed EBITDA several times over.
Strategy
Stated strategic themes (FY2026 AR and Sagar group communications, paraphrased):
-
Restart and stabilise the Dachepalli plant. Grinding resumed on 12 April 2023 and plant operations continued through FY2026.
-
Modernise and expand DCW. New six-stage preheater (commissioned 23 Oct 2025). Clinker capacity from 1.65 to 2.30 MTPA. Grinding from 1.82 to 3.00 MTPA (commercial from 28 Sep 2026).
-
Regulatory compliance. Achieve 25% Minimum Public Shareholding (done March 2026 through two OFS tranches).
-
Structural simplification. Merge into Sagar Cements: in-principle approval on 30 Mar 2026, scheme approved on 5 Jun 2026.
Initiatives in the last 24 months.
Medium-term targets and guidance (from Sagar, since ACL issues no standalone guidance):
ACL utilisation: about 41% in Q1 FY2027. Management said it had reached about 50% and targets about 60% by end-FY2027, with 60–70% over the medium term (DSIJ / ICICI Securities).
Sagar group volume: about 7.0 MT for FY2027, excluding clinker, about 15–16% growth. Double-digit volume growth expected in FY2027 and FY2028.
Sagar group EBITDA/tonne: INR 500–550 for FY2027 guidance (Quartr summary of Q1 FY2027 call).
Sagar FY2027 capex: budgeted at about INR 291 crore, mainly maintenance plus project completion (ICICI Securities, Jan 2026).
Cost programmes. Sagar-level waste heat recovery systems (2.80 MW commissioned 12 May 2026 and the balance 1.55 MW later at a Sagar unit) and other efficiency projects. No ACL-specific cost-reduction target with a quantified saving is publicly disclosed.
Products & Services
The company does not publish a product-level catalogue. The table below combines what ACL's historical materials state with the grades sold across the Sagar platform, through which ACL's output is now marketed.
Brand architecture. Sagar markets its cement under the "Sagar" brand (MoneyWorks4Me company profile). Commentary on the merger notes that simplifying brand architecture is one of its aims (Sahi.com). Whether ACL cement now ships under the Sagar brand, a legacy ACL brand, or both is not publicly disclosed in the sources reviewed.
Launch / latest-version dates. No product launches are disclosed. The material "product" event is the capacity upgrade at DCW: the six-stage preheater in October 2025 and grinding expansion in September 2026.
Product Portfolio
| Product / brand | Description | Key specs | Target customer | Status | Pricing model |
|---|---|---|---|---|---|
"Durga Prasad" (historic trade name) | Historic ACL cement brand | Grades not specified in sources | Retail / trade | Historical brand cited by MarketsMojo. | Per-bag dealer pricing (market) |
Ordinary Portland Cement, 53 grade | High-early-strength cement | 53 MPa 28-day strength class (BIS standard) | RCC, infrastructure, precast | Sold in Sagar group (MoneyWorks4Me). ACL-specific production mix not disclosed. | Market-based, per 50 kg bag |
Ordinary Portland Cement, 43 grade | General-purpose OPC | 43 MPa class | Masonry, general construction | Sold in Sagar group | Market-based |
Portland Pozzolana Cement (PPC) | Blended cement with fly ash | Pozzolanic blend; lower clinker factor | Housing / retail | Sold in Sagar group | Market-based |
Sulphate Resistant Cement (SRC) | Specialty cement for aggressive soils/water | Low C3A | Marine, foundations, sewage works | Sold in Sagar group | Market-based / tender |
Clinker (intermediate) | Semi-finished product | From DCW kiln (clinker capacity 1.65 → 2.30 MTPA project) | Group grinding units / third parties | Sagar excludes clinker from its 7 MT FY2027 cement volume target | Inter-company / market |
Financial Narrative
Basis. Standalone Ind AS figures for fiscal years ending 31 March, in INR crore.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Revenue by Segment (%)
| Segment | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Cement and cement related products (INR Cr) | 268.1 | 274.05 | 442.49 |
Total revenue from operations (INR Cr) | 268.1 | 274.05 | 442.49 |
Segment share of total revenue (%) | 100 | 100 | 100 |
Results by Segment and Segment Margins & Growth (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Segment EBITDA (INR Cr) | -3 | -29 | 16.06 |
Segment EBITDA margin (%) | -1.1 | -10.6 | 3.6 |
Segment EBIT (INR Cr) | -59 | -101 | -68.4 |
Pre-tax income (INR Cr) | -107 | -174.51 | -156.48 |
YoY revenue growth (%) | — | 2.2 | 61.5 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 0 | 0 | 268.1 | 274.05 | 442.49 |
Other income (INR Cr) | -1 | 972 | 23 | 1 | 9.90 |
Gross profit, aggregator basis (INR Cr) | -7.3 | -3.5 | 84.3 | 83.5 | 174.9 |
EBITDA (INR Cr) | -31 | -25 | -3 | -29 | 16.06 |
Depreciation & amortisation (INR Cr) | 47 | 47 | 56 | 72 | 84.45 |
Operating income / EBIT (INR Cr) | -78 | -72 | -59 | -101 | -68.4 |
Finance costs (INR Cr) | 158 | 16 | 71 | 75 | 97.99 |
Exceptional items (INR Cr) | — | — | — | -6.26 | 0 |
Pre-tax income (INR Cr) | -236 | 884 | -107 | -174.51 | -156.48 |
Tax expense / (credit) (INR Cr) | 0 | -66 | -41 | -22.4 | -89.32 |
Net income (INR Cr) | -236 | 950 | -66 | -152.11 | -67.16 |
EPS basic (INR) | -8.05 | 103.03 | -7.12 | -16.50 | -7.29 |
EPS diluted (INR) | -8.05 | 103.03 | -7.12 | -16.50 | -7.29 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Gross margin, aggregator basis (%) | 31.4 | 30.4 | 39.5 |
EBITDA margin (%) | -1.1 | -10.6 | 3.6 |
Operating (EBIT) margin (%) | -22.0 | -36.9 | -15.5 |
Pre-tax margin (%) | -39.9 | -63.7 | -35.4 |
Net margin (%) | -24.6 | -55.5 | -15.2 |
Revenue growth YoY (%) | — | 2.2 | 61.5 |
Cost line
| Cost line | FY2026 (INR Lakh) | % of revenue from operations |
|---|---|---|
Cost of materials consumed | 6,420 | 14.5 |
Change in inventories | 1,040 | 2.4 |
Employee benefits | 1,716 | 3.9 |
Power and fuel | 17,783 | 40.2 |
Freight and forwarding | 9,929 | 22.4 |
Other expenses | 5,755 | 13.0 |
Finance costs | 9,799 | 22.1 |
Depreciation and amortisation | 8,445 | 19.1 |
Total expenses | 60,887 | 137.6 |
Income Statement and Per-Share Data (Quarterly)
| Metric | Q1FY2025 | Q2FY2025 | Q3FY2025 | Q4FY2025 | Q1FY2026 | Q2FY2026 | Q3FY2026 | Q4FY2026 | Q1FY2027 |
|---|---|---|---|---|---|---|---|---|---|
Revenue (INR Cr) | 63 | 55 | 66 | 89 | 99.53 | 78 | 110 | 154.85 | 142.17 |
EBITDA (INR Cr) | -5 | -10 | -8 | -5 | 7 | -4 | 5 | 9 | 3.74 |
Finance costs (INR Cr) | 18 | 18 | 19 | 20 | 20.54 | 21 | 26 | 30.21 | 31.94 |
Pre-tax income (INR Cr) | -36 | -45 | -44 | -50 | -29.62 | -42 | -44 | -40.80 | -47.77 |
Net income (INR Cr) | -24 | -35 | -44 | -50 | -29.62 | -41.92 | -44 | 48.52 | -35.93 |
EPS (INR) | -2.56 | -3.78 | -4.74 | -5.41 | -3.21 | -4.55 | -4.79 | 5.26 | -3.90 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 871 | 917 | 1,080 | 1,144 | 1,420 |
Net fixed assets (INR Cr) | 832 | 738 | 815 | 759 | 977 |
Capital work in progress (INR Cr) | 0 | 26 | 0 | 106 | 6 |
Other (current and non-current) assets (INR Cr) | 39 | 152 | 265 | 280 | 437 |
Total borrowings (INR Cr) | 970 | 525 | 675 | 757 | 1,127 |
Other liabilities (INR Cr) | 817 | 36 | 107 | 243 | 212 |
Equity share capital (INR Cr) | 294 | 92 | 92 | 92 | 92.17 |
Reserves / other equity (INR Cr) | -1,210 | 263 | 205 | 52 | -11.43 |
Total equity (INR Cr) | -916 | 355 | 297 | 144 | 80.74 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (INR Cr) | 151 | -1 | -27 | 60 | -25 |
Investing cash flow (INR Cr) | 1 | -35 | -96 | -81 | -248 |
Financing cash flow (INR Cr) | -152 | 80 | 90 | 11 | 274 |
Capex, derived (INR Cr) | 0 | 27 | 90 | 77 | 221 |
Free cash flow (INR Cr) | 151 | -28 | -117 | -17 | -246 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) | — | — | -20.2 | -68.8 | -59.8 |
ROA (%) | -26.1 | 106.2 | -6.6 | -13.7 | -5.2 |
ROCE, aggregator (%) | -45 | -15 | -6 | -11 | -6 |
Debt / equity (x) | — | 1.48 | 2.27 | 5.26 | 13.96 |
Gross debt / EBITDA (x) | — | — | — | — | 70.2 |
Interest coverage, EBITDA / interest (x) | -0.20 | -1.56 | -0.04 | -0.39 | 0.16 |
Asset turnover (x) | — | — | 0.27 | 0.25 | 0.34 |
Debtor days | — | — | 52 | 40 | 38 |
Inventory days | — | — | 930 | 1,019 | 398 |
Payable days | — | — | 1,172 | 2,164 | 575 |
Cash conversion cycle (days) | — | — | -190 | -1,105 | -138 |
Revenue by Region and Region Margins & Growth (%)
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
India (INR Cr) | 268.1 | 274.05 | 442.49 |
Outside India (INR Cr) | 0 | 0 | 0 |
India growth YoY (%) | — | 2.2 | 61.5 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Price (19 Oct 2026, intraday) | INR 39.1 | Screener |
Market capitalisation | About INR 360 crore | Screener |
52-week high / low | INR 84.2 / 37.2 | Screener |
1-year price change | -48% | Screener |
3-year price CAGR | -27% a year | Screener |
5-year price CAGR | +20% a year (base distorted by pre-IBC period) | Screener |
10-year price CAGR | +16% a year | Screener |
OFS floor price (Mar 2026) | INR 52 | ScanX |
Price on merger announcement (5 Jun 2026) | About INR 55.3–55.5 | Reuters / Stockopedia; TradeBrains |
Share Price
| Metric | Mar 2026 OFS | Jun 2026 | Jul 2026 | Oct 2026 |
|---|---|---|---|---|
ACL share price (INR) | 52 | 55.3 | 46.53 | 39.1 |
Valuation Multiples
| Multiple | ACL | Comment |
|---|---|---|
P/B | About 4.46x | Book value INR 8.76 per share (Screener) |
EV (approx.) | About INR 1,487 crore | Market cap INR 360 crore + aggregator borrowings INR 1,127 crore (Mar 2026). Cash undisclosed, so EV is overstated by any cash. Using company-disclosed borrowings of INR 702.98 crore instead gives EV of about INR 1,063 crore. |
EV / Sales (TTM revenue INR 485 crore) | About 3.1x (2.2x on the lower debt figure) | — |
EV / EBITDA (TTM EBITDA about INR 13 crore) | More than 80x; not meaningful | — |
EV per tonne of grinding capacity (3.00 MTPA) | About INR 3,500–5,000 million per MTPA | Derived |
Capital Markets
| Item | Status |
|---|---|
Sell-side coverage | None. Zero analysts cover ACL (Simply Wall St). Sagar is covered by about 16 analysts. ICICI Securities rated Sagar BUY (Jan 2026, target INR 220) and later HOLD (Q1 FY2027, per DSIJ). |
Dividend history | No dividends in any year shown (FY2015–FY2026) |
Dividend policy | Not publicly disclosed; payout constrained by accumulated losses |
Credit Ratings
| Agency | Instrument | Rating / outlook | Date | Source |
|---|---|---|---|---|
India Ratings (Ind-Ra) | Bank facilities, INR 938.97 crore (SBI term loan INR 563.97 crore; Yes Bank term loan INR 150 crore; working capital) | IND BBB / Stable; IND A3+ | 2 Jul 2026 (affirmed) | FilingReader summary |
India Ratings | Bank facilities, INR 986.97 crore | IND BBB / RWDI; IND A3+ / RWDI | 8 Apr 2026 | Ind-Ra letter on NSE |
CARE Ratings | Legacy bank facilities | Withdrawn (no amount outstanding) | Oct 2024 | CARE |
Moody's / S&P / Fitch (international) | — | Not rated | — | — |
Parent (Sagar Cements), Ind-Ra | Debt | IND BBB+ / Negative | As cited Apr 2026 | Ind-Ra letter |
Analyst Conclusions
Management guidance (via Sagar)
| Metric | Guidance | Source |
|---|---|---|
| ACL utilisation | About 60% by end-FY2027; 60–70% medium term (from about 41% in Q1 FY2027) | DSIJ / ICICI Securities |
| Sagar group volume FY2027 | About 7.0 MT, excluding clinker (+15–16%) | Quartr; Arthneeti |
| Sagar group EBITDA/t FY2027 | INR 500–550 | Quartr |
| South India demand FY2027 | +8–10% | DSIJ |
| Andhra capex | About INR 140 crore pending, completed Sep 2026 | Arthneeti; ACL Reg. 30 |
Consensus estimates for ACL do not exist; it has no coverage.
Bull case
-
Operating leverage from capacity that is now in place. Grinding rose 64.8% to 3.00 MTPA on 28 Sep 2026, and the six-stage preheater is running. Moving from about 41% to the targeted 60% utilisation spreads a fixed-cost base that includes INR 84 crore of depreciation and about INR 17 crore of employee cost. Each tonne of extra volume should therefore lift margins from the FY2026 EBITDA margin of 3.6%.
-
Merger crystallises value and uses tax losses. The 29:98 swap gives minorities liquid exposure to an 11.75 MTPA group. ACL's accumulated losses (DTA of INR 89.32 crore already recognised) shelter Sagar's future profits. The Appointed Date of 1 April 2026 means FY2027 losses are already effectively absorbed into Sagar's economics.
-
Capex cycle over; demand tailwinds local. With the expansion complete, FCF should swing from FY2026's INR –246 crore. Dachepalli's closeness to Amaravati gives ACL a logistics advantage in a market management expects to grow 8–10%.
Bear case
-
Interest burden swamps operating improvement. Q1 FY2027 finance costs of INR 31.94 crore were about 8.5x EBITDA of INR 3.74 crore. Even at 60% utilisation and peer-level EBITDA/t of about INR 500, the debt load (INR 703–1,127 crore depending on definition) leaves little equity value on a standalone basis.
-
Pricing environment is hostile. Sagar group realisation fell 6.4% YoY in Q1 FY2027, and EBITDA/t of INR 451 is less than half UltraTech's INR 1,092. Tier-2 players face a deteriorating outlook (Ind-Ra) as consolidators expand in the South.
-
Minority value is capped and contingent. ACL's value is now essentially 0.2959 Sagar shares less completion risk. Sagar itself lost money in Q1 FY2027 (consolidated INR –28.1 crore) and carries a Negative outlook. Approval delays or a parent-level downturn would hit ACL holders without any standalone offset. Promoter encumbrance of about 31.7% adds governance overhang.
Catalysts and monitorables (next 12 months)
| Catalyst | Expected timing | What to watch |
|---|---|---|
| Q2 FY2027 results | 30 Oct 2026 | First quarter with expanded grinding (two days); volumes, EBITDA/t, finance cost |
| Q3 FY2027 results | Jan 2027 | Utilisation versus the 60% target; realisation trend |
| SEBI / exchange observation letters on the scheme | H2 2026 | No-objection or modification |
| NCLT-convened shareholder and creditor meetings | 2,027 | Minority vote on 29:98 ratio |
| NCLT sanction and effective date | 2,027 | Delisting of ACL; issue of Sagar shares |
| Ind-Ra surveillance | Mid-2027 or earlier | Rating action on merger progress |
| Fuel and power costs | Ongoing | Gulf / imported coal and pet coke prices; APERC orders |
| Southern cement pricing | Ongoing | Per-bag price changes in AP/Telangana |
| Sagar share price versus INR 132 parity | Ongoing | Merger arbitrage spread |
Analyst verdict
Andhra Cements Limited is no longer best analysed as a standalone company. It is a merger-arbitrage instrument wrapped around a turnaround plant. The operating story is real but incomplete. Under Sagar's ownership, a plant that was idle from February 2020 to April 2023 now has a modern six-stage preheater and 3.00 MTPA of grinding capacity. FY2026 revenue rose 61.5% to INR 442.49 crore and EBITDA turned positive for the first time since the restart.
The financial story is still weak. EBITDA of INR 16 crore against finance costs of INR 98 crore, debt/equity near 14x and net worth eroded to about INR 81 crore all show that ACL's equity value depends on its parent. Ind-Ra acknowledges this by rating ACL purely on parent linkage.
The 5 June 2026 Scheme of Amalgamation therefore dominates valuation. Each ACL share becomes 0.2959 Sagar shares, so ACL's fair value is Sagar's price times that ratio, discounted for the time and risk to NCLT sanction, plausibly a 2027 event. At INR 39.1, ACL implies a Sagar price of about INR 132. Investors should compare that with Sagar's live quote: a meaningful discount would represent the arbitrage spread, and a premium would signal mispricing or approval doubts.
Fundamentally, the merger is rational for the group. It removes duplicated listing costs, consolidates expansion capacity in Andhra Pradesh, and lets Sagar use ACL's tax losses. Minority holders give up standalone optionality, which on the evidence is limited, in exchange for a diversified, larger but currently loss-making parent with a Negative-outlook rating.
Verdict: Neutral / event-driven. ACL's risk-reward now tracks Sagar's fundamentals and scheme timing more than its own plant performance. The key monitorables are Q2–Q3 FY2027 utilisation, regional realisations, and regulatory progress on the amalgamation. Significant data gaps remain, including cash, the debt maturity schedule, segment volumes and ESG metrics. They should be filled from the FY2026 Annual Report before any capital commitment.
Source list (primary and secondary)
-
NSE: ACL Q1 FY2027 unaudited results and BSR & Co limited review report (27 Jul 2026)
-
NSE: ACL FY2026 audited results (13 May 2026)
-
NSE: ACL Q1 FY2026 results (21 Jul 2025)
-
NSE: ACL Reg. 30 disclosure, six-stage preheater (23 Oct 2025)
-
NSE: Ind-Ra rating letter, Rating Watch (8 Apr 2026)
-
NSE / BSE: Sagar Cements Q1 FY2027 presentation (27 Jul 2026); Sagar Q3 FY2026 presentation and call transcript (Jan 2026); Sagar Reg. 30 OFS disclosure (8 Jan 2026)
-
BSE: Sagar letter on ACL board reconstitution (8 Mar 2023); ACL director appointments (14 Apr 2023); Sagar acquisition presentation (Feb 2023)
-
CARE Ratings: rating withdrawal (Oct 2024) and prior rationales
-
Insolvency Tracker (2022–2023); LiveLaw (Apr 2022); Business Standard (Oct 2022); Global Cement
-
Reuters via Stockopedia (Feb 2023; Jun 2026); TradeBrains; FilingReader; ScanX; Sahi.com; CemNet; MoneyWorks4Me
-
ICICI Securities research on Sagar Cements (Jul 2025; Jan 2026); DSIJ; Quartr; Arthneeti
-
CRISIL rating letter on UltraTech (Aug 2026); CompoundingAI; NBMCW (Ind-Ra sector outlook)
-
Aggregators: Screener.in (C-MOTS), StockAnalysis, Trendlyne, Simply Wall St, IIFL, MarketsMojo, Corpveda, Infyner, SustainabilityReports.com
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure at ACL | Prior / concurrent roles | Education | Age | Source |
|---|---|---|---|---|---|---|
Dr. S. Anand Reddy (Sammidi Anand Reddy), DIN 00123870 | Managing Director (Executive, Non-Independent) | Director from 16 Feb / 7 Mar 2023; MD since 14 Apr 2023 (5-year term) | Managing Director of Sagar Cements since 2018. Joined Sagar as Director (Marketing & Projects); later Joint MD. | M.B.B.S. | About 61 | ACL BSE letter 14 Apr 2023; Simply Wall St |
Kolluru Prasad | Chief Financial Officer | Since 7 Mar 2023 | — | — | — | MCA registry via Corpveda |
G. Tirupati Rao | Company Secretary & Compliance Officer; also Nodal Officer (from 19 Nov 2024) | — | — | FCS (M. No. F2818) | — | NSE filings; Corpveda |
“—” = not publicly disclosed.
Board of Directors
| Name | Category | Appointed | Notes | Source |
|---|---|---|---|---|
K. Venkata Vishnu Raju (Kalidindi Venkata Vishnu Raju) | Independent Director, Chairman | 5 Jun 2023 | Chair per Simply Wall St / Geojit listing | Corpveda; Simply Wall St |
Dr. S. Anand Reddy | Managing Director | 2023 | See above | — |
S. Sreekanth Reddy (Sammidi Sreekanth Reddy), DIN 00123889 | Non-Executive, Non-Independent | 7 Mar 2023 | Joint Managing Director of Sagar Cements | Sagar BSE letter 8 Mar 2023 |
Mrs. S. Rachana (Rachana Sammidi) | Non-Executive Director | 7 Mar 2023 | Non-executive director of Sagar Cements. Simply Wall St labels her independent, but the Sagar nomination letter indicates non-independent. Discrepancy noted. | Sagar BSE letter 8 Mar 2023 |
R. Ravichandran (Rajagopal Ravichandran), DIN 00110930 | Independent Director | 14 Apr 2023 | Whole-time Director, Anjani Foods; Independent Director, Sagar Cements; formerly Director, Vijay Cements (1992–97) and Elico Healthcare (1997–2009) | ACL BSE letter 14 Apr 2023 |
V. H. Ramakrishnan (Valliyur Hariharan Ramakrishnan), DIN 00143948 | Independent Director | 5 Jun 2023 | — | Corpveda |
Mrs. Rekha Onteddu | Independent Director | 5 Jun 2023 | — | Corpveda |
Dr. S. Anand Reddy | MD | 60,000 | Appears to be sitting fees only; executive remuneration is drawn at Sagar (INR 37.15 million at Sagar) | Simply Wall St (ACL and Sagar pages) |
K. V. Vishnu Raju | Independent Chair | 600,000 | Sitting fees / commission | Simply Wall St |
S. Sreekanth Reddy | Non-Executive | 600,000 | Sitting fees | Simply Wall St |
V. H. Ramakrishnan | Independent | 600,000 | Sitting fees | Simply Wall St |
Mrs. S. Rachana | Non-Executive | 600,000 | Sitting fees | Simply Wall St |
Other Independent Director | Independent | 400,000 | Sitting fees | Simply Wall St |
Shareholding Trend
| Holder category | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|
Promoter: Sagar Cements Ltd (%) | 90.00 | 90.00 | 75.00 | 75.00 |
Domestic institutions (%) | 0.34 | 0.34 | 0.34 | 0.34 |
Foreign institutions (%) | 0 | 0 | 0 | 0 |
Public / retail (%) | 9.66 | 9.65 | 24.65 | 24.66 |
Number of shareholders | 90,718 | 91,196 | 85,276 | 83,782 |
Competitive Landscape
Key Competitors
| # | Competitor | Relevance to ACL's markets | Comparative data (where verified) |
|---|---|---|---|
| 1 | UltraTech Cement (Aditya Birla), including India Cements and Kesoram assets | India's largest producer. India Cements consolidated from Dec 2024. Strong South presence. | Capacity about 200 MTPA including 5.4 MTPA overseas (Jun 2026); FY2026 EBITDA/t INR 1,092; FY2026 volume +14% (CRISIL rating letter, Aug 2026) |
| 2 | India Cements (UltraTech subsidiary) | Major legacy southern player | Q4 FY2026 EBITDA/t INR 497; gross debt cut to about INR 1,733 crore (CompoundingAI) |
| 3 | Ambuja Cements / ACC (Adani), including Penna Cement assets | Penna gives Adani a large AP/Telangana base | — |
| 4 | Dalmia Bharat | Lost the ACL bid in 2022; strong South franchise | — |
| 5 | The Ramco Cements | Southern incumbent with AP grinding presence | — |
| 6 | Shree Cement | National player with southern capacity | — |
| 7 | Bharathi Cement (Vicat group) | Kadapa-based AP major | — |
| 8 | JSW Cement | Southern / AP presence | — |
| 9 | My Home Industries (Maha Cement) | Telangana/AP regional leader | — |
| 10 | NCL Industries, KCP Ltd, Deccan Cements | Smaller AP/Telangana listed peers | — |
| 11 | Sagar Cements (parent) | Not a competitor; ACL's acquirer and merger partner | FY2026 consolidated revenue INR 2,650 crore; Q1 FY2027 EBITDA/t INR 451; capacity 11.75 MTPA (Sep 2026) |
Peer Comparison FY2026
| Metric | Andhra Cements | Sagar Cements (consolidated) | UltraTech | India Cements |
|---|---|---|---|---|
Latest FY revenue (INR Cr) | 442.49 (FY2026) | 2650 (FY2026) | — | — |
Revenue growth (latest, %) | 61.5 (FY2026) | 5 (Q1 FY2027 YoY) | — | — |
EBITDA margin (latest, %) | 3.6 (FY2026); 2.6 (Q1 FY2027) | 10.3 (Q1 FY2027) | — | 15.1 (Q4 FY2026) |
EBITDA per tonne (INR) | — | 451 (Q1 FY2027) | 1092 (FY2026) | 497 (Q4 FY2026) |
Capacity (MTPA) | 3.00 grinding (DCW) | 11.75 (group) | ~200 | — |
“—” = not publicly disclosed.



